Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 51

1.

Moderate risk-adapted dose escalation with three-dimensional conformal radiotherapy of localized prostate cancer from 70 to 74 Gy. First report on 5-year morbidity and biochemical control from a prospective Austrian-German multicenter phase II trial.

Goldner G, Bombosch V, Geinitz H, Becker G, Wachter S, Glocker S, Zimmermann F, Wachter-Gerstner N, Schrott A, Bamberg M, Molls M, Feldmann H, Pötter R.

Strahlenther Onkol. 2009 Feb;185(2):94-100. doi: 10.1007/s00066-009-1970-3. Epub 2009 Feb 25.

PMID:
19240995
[PubMed - indexed for MEDLINE]
2.

The use of conformal radiotherapy and the selection of radiation dose in T1 or T2 low or intermediate risk prostate cancer - a systematic review.

Brundage M, Lukka H, Crook J, Warde P, Bauman G, Catton C, Markman BR, Charette M; Cancer Care Ontario Practice Guidelines Initiative Genitourinary Cancer Disease Site Group.

Radiother Oncol. 2002 Sep;64(3):239-50. Review.

PMID:
12242112
[PubMed - indexed for MEDLINE]
3.

Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapy.

Vargas C, Martinez A, Kestin LL, Yan D, Grills I, Brabbins DS, Lockman DM, Liang J, Gustafson GS, Chen PY, Vicini FA, Wong JW.

Int J Radiat Oncol Biol Phys. 2005 Aug 1;62(5):1297-308. Review.

PMID:
16029785
[PubMed - indexed for MEDLINE]
4.

Comparison of late rectal toxicity from conventional versus three-dimensional conformal radiotherapy for prostate cancer: analysis of clinical and dosimetric factors.

Lee CM, Lee RJ, Handrahan DL, Sause WT.

Urology. 2005 Jan;65(1):114-9. Review.

PMID:
15667875
[PubMed - indexed for MEDLINE]
5.

Technological advances in external-beam radiation therapy for the treatment of localized prostate cancer.

Leibel SA, Fuks Z, Zelefsky MJ, Hunt M, Burman CM, Mageras GS, Chui CS, Jackson A, Amols HI, Ling CC.

Semin Oncol. 2003 Oct;30(5):596-615. Review.

PMID:
14571409
[PubMed - indexed for MEDLINE]
6.
7.

[Review on the effectiveness of prostate cancer brachytherapy].

Inciūra A, Jarusevicus L, Vaiciūnas K, Juozaityte E.

Medicina (Kaunas). 2009;45(8):660-71. Review. Lithuanian.

PMID:
19773626
[PubMed - indexed for MEDLINE]
Free Article
8.

Systematic review of the effect of radiation dose on tumor control and morbidity in the treatment of prostate cancer by 3D-CRT.

van Tol-Geerdink JJ, Stalmeier PF, Pasker-de Jong PC, Huizenga H, van Lin EN, Schimmel EC, Leer JW, van Daal WA.

Int J Radiat Oncol Biol Phys. 2006 Feb 1;64(2):534-43. Epub 2005 Oct 24. Review.

PMID:
16246497
[PubMed - indexed for MEDLINE]
9.

Higher-than-conventional radiation doses in localized prostate cancer treatment: a meta-analysis of randomized, controlled trials.

Viani GA, Stefano EJ, Afonso SL.

Int J Radiat Oncol Biol Phys. 2009 Aug 1;74(5):1405-18. doi: 10.1016/j.ijrobp.2008.10.091. Review.

PMID:
19616743
[PubMed - indexed for MEDLINE]
10.

[Conformal radiotherapy of prostate cancer].

Hennequin C, Quero L, Soudi H, Sergent G, Maylin C.

Ann Urol (Paris). 2006 Aug;40(4):233-40. Review. French.

PMID:
16970066
[PubMed - indexed for MEDLINE]
11.

Adjuvant radiotherapy for patients with locally advanced prostate cancer--a new standard?

Ganswindt U, Stenzl A, Bamberg M, Belka C.

Eur Urol. 2008 Sep;54(3):528-42. doi: 10.1016/j.eururo.2008.06.059. Epub 2008 Jun 23. Review.

PMID:
18602742
[PubMed - indexed for MEDLINE]
12.

The case for dose escalation versus adjuvant androgen deprivation therapy for intermediate risk prostate cancer.

Pickles T, Pollack A.

Can J Urol. 2006 Apr;13 Suppl 2:68-71. Review.

PMID:
16672133
[PubMed - indexed for MEDLINE]
13.

[pT3R1 prostate cancer : Immediate or delayed radiotherapy after radical prostatectomy?].

Bottke D, Wiegel T.

Urologe A. 2008 Nov;47(11):1431-5. doi: 10.1007/s00120-008-1724-3. Review. German.

PMID:
18810383
[PubMed - indexed for MEDLINE]
14.

Update on the treatment of prostate cancer with external beam irradiation.

Horwitz EM, Hanlon AL, Hanks GE.

Prostate. 1998 Nov 1;37(3):195-206. Review.

PMID:
9792138
[PubMed - indexed for MEDLINE]
15.

[Conformal radiotherapy of prostatic cancer: a general review].

Chauvet B, Oozeer R, Bey P, Pontvert D, Bolla M.

Cancer Radiother. 1999 Sep-Oct;3(5):393-406. Review. French.

PMID:
10572509
[PubMed - indexed for MEDLINE]
16.

Evidence-based radiation oncology: definitive, adjuvant and salvage radiotherapy for non-metastatic prostate cancer.

Jereczek-Fossa BA, Orecchia R.

Radiother Oncol. 2007 Aug;84(2):197-215. Epub 2007 May 29. Review.

PMID:
17532494
[PubMed - indexed for MEDLINE]
17.

[Radiotherapy of prostate carcinoma].

Zimmermann F, Geinitz H, Molls M.

Praxis (Bern 1994). 2001 Sep 20;90(38):1632-40. Review. German.

PMID:
11675916
[PubMed - indexed for MEDLINE]
18.

Percutaneous radiotherapy for low-risk prostate cancer: options for 2007.

Bottke D, Wiegel T.

World J Urol. 2007 Mar;25(1):53-7. Epub 2007 Feb 15. Review.

PMID:
17364213
[PubMed - indexed for MEDLINE]
19.

70 Gy or more: which dose for which prostate cancer?

Ganswindt U, Paulsen F, Anastasiadis AG, Stenzl A, Bamberg M, Belka C.

J Cancer Res Clin Oncol. 2005 Jul;131(7):407-19. Epub 2005 May 11. Review.

PMID:
15887028
[PubMed - indexed for MEDLINE]
20.

Dose escalation in locally advanced carcinoma of the prostate.

Blanco AI, Michalski JM.

Semin Radiat Oncol. 2003 Apr;13(2):87-97. Review.

PMID:
12728438
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk